Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Breast Adjuvant Escalation

Michael Untch

MD, PhD

🏢Helios Klinikum Berlin Buch🌐Germany

Head of Multidisciplinary Breast Cancer Center

70
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Michael Untch is a leader in German Breast Group trials for neoadjuvant and adjuvant therapy. He has contributed to pivotal studies including GeparSepto and GeparOcto. His work has shaped neoadjuvant chemotherapy standards for HER2 positive and triple negative breast cancer. He is recognized internationally for his clinical trial leadership.

Share:

🧪Research Fields 研究领域

breast cancer
neoadjuvant therapy
HER2 positive
adjuvant therapy
clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Michael Untch 的研究动态

Follow Michael Untch's research updates

留下邮箱,当我们发布与 Michael Untch(Helios Klinikum Berlin Buch)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment